Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Priyalata, Shetty"'
Autor:
Rubel Chakravarty, Nirvik Sen, Sourav Patra, A. Rajeswari, Priyalata Shetty, Krishna Kumar Singh, Sudipta Chakraborty
Publikováno v:
Chemical Engineering Journal Advances, Vol 13, Iss , Pp 100433- (2023)
Microfluidics based liquid-liquid extraction is emerging as an enabling and powerful technology in radiochemical separations of medically important radioisotopes. In this study, we report the production of high specific activity 64Cu via 64Zn (n, p)
Externí odkaz:
https://doaj.org/article/0f9504715e3d4c46a57fbf3d85e1df1d
Autor:
Bijaideep Dutta, Sandeep B. Shelar, K. C. Barick, Priyalata Shetty, Rubel Chakravarty, Sudipta Chakraborty, Swati Checker, H. D. Sarma, P. A. Hassan
Publikováno v:
Materials Advances. 4:195-204
Polyphosphate grafted Fe3O4 nanomagnets for pH-responsive drug delivery and their in vivo tracking by 64Cu and 177Lu radiolabeling.
Autor:
Rahul Krishnatry, Rubel Chakravarty, Haladhar Dev Sarma, K. V. Vimalnath Nair, Venkatesh Rangarajan, K. C. Jagadeesan, Sudipta Chakraborty, A. Rajeswari, Priyalata Shetty
Publikováno v:
Annals of Nuclear Medicine. 34:899-910
Copper-64 is a useful theranostic radioisotope that is attracting renewed interest from the nuclear medicine community in the recent times. This study aims to demonstrate the utility of research reactors to produce clinical-grade 64Cu via 63Cu(n,γ)6
Autor:
Priyalata Shetty, Rakhee Vatsa, Jaya Shukla, Bhagwant Rai Mittal, Rubel Chakravarty, Haladhar Dev Sarma, Sudipta Chakraborty, Ashutosh Dash, Chandan Kumar, K.V. Vimalnath
Publikováno v:
Radiochimica Acta. 108:661-672
Radiolabeled macrocyclic bisphosphonate ligands have recently been demonstrated to be highly efficacious in treatment of patients with painful bone metastases. Herein, we report a robust protocol for formulation of therapeutically relevant doses of 1
Autor:
Rubel, Chakravarty, Priyalata, Shetty, K V Vimalnath, Nair, Ardhi, Rajeswari, K C, Jagadeesan, Haladhar Dev, Sarma, Venkatesh, Rangarajan, Rahul, Krishnatry, Sudipta, Chakraborty
Publikováno v:
Annals of nuclear medicine. 34(12)
Copper-64 is a useful theranostic radioisotope that is attracting renewed interest from the nuclear medicine community in the recent times. This study aims to demonstrate the utility of research reactors to produce clinical-gradeCopper-64 was produce
Autor:
Rubel, Chakravarty, Ardhi, Rajeswari, Priyalata, Shetty, K C, Jagadeesan, Ramu, Ram, Sachin, Jadhav, Haladhar Dev, Sarma, Ashutosh, Dash, Sudipta, Chakraborty
Publikováno v:
Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine. 165
Copper-64 is an excellent theranostic radiometal that is gaining renewed attention of the clinical community in the recent times. In order to meet the increasing demand of this radiometal, we have demonstrated the viability of its production via
Autor:
Rubel Chakravarty, Haladhar Dev Sarma, Sudipta Chakraborty, Ashutosh Dash, Priyalata Shetty, Deep Prakash, K.V. Vimalnath, P.K. Sinha, J. B. Sharma
Publikováno v:
Journal of Labelled Compounds and Radiopharmaceuticals. 61:522-532
Since the inception of radiation synovectomy, a host of radioactive colloids and microparticles incorporating suitable therapeutic radionuclides have been proposed for the treatment of arthritis. The present article reports the synthesis and evaluati
Autor:
Jaya Shukla, Rubel Chakravarty, Sudipta Chakraborty, Rakhee Vatsa, Soumen Das, Priyalata Shetty, Bhagwant Mittal
Publikováno v:
Nuclear Medicine and Biology. :S99-S100
Autor:
Shahiralm Khan Mohammed, K.V. Vimalnath, J. Nuwad, Priyalata Shetty, A. Rajeswari, Haladhar Dev Sarma, Sudipta Chakraborty, Ashutosh Dash
Publikováno v:
Applied Radiation and Isotopes. 116:85-91
In the present article we describe a systematic approach pursued for the synthesis of (32)P-labeled hydroxyapatite (HA) microparticles (1-10µm size range) using no carrier added (NCA) (32)P produced in a nuclear reactor and animal evaluation of its
Autor:
Sudipta Chakraborty, Ashutosh Dash, Priyalata Shetty, K.V. Vimalnath, Rubel Chakravarty, Ishita B. Sen
Publikováno v:
Journal of Labelled Compounds and Radiopharmaceuticals. 59:364-371
Targeted radionuclide therapy using (177) Lu-labeled peptidomimetic inhibitor of prostate specific membrane antigen (PSMA) viz. PSMA-617 is emerging as one the most effective strategies for management of metastatic prostate cancer, which is one of th